Hainan Poly Pharm. Co., Ltd.
As of 18 November 2026, for the company name Hainan Poly Pharm. Co., Ltd. as recorded, the chemical-drug catalogue lists 67 active records with this name as holder; 20 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
96 acceptance records as first applicant, grouped into 43 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Cyclophosphamide for Injection 2 records · Latest accepted 2026/08/06
Generic · 2
Vancomycin Hydrochloride for Injection 2 records · Latest accepted 2026/05/07
Supplement · 1Generic · 1
Phenylephrine Hydrochloride Injection 4 records · Latest accepted 2026/03/28
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600619 | Supplement | 2026/03/28 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHB2600618 | Supplement | 2026/03/28 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2300995 | Generic | 2023/04/07 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2300994 | Generic | 2023/04/07 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Idarubicin Hydrochloride Injection 1 records · Latest accepted 2025/11/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503934 | Generic | 2025/11/12 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Ioversol Injection 1 records · Latest accepted 2025/10/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503723 | Generic | 2025/10/17 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Bivalirudin for Injection 2 records · Latest accepted 2025/10/15
Supplement · 2
Bumetanide Injection 1 records · Latest accepted 2025/07/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502591 | Generic | 2025/07/18 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
维生素B6注射液 · No verified English name 1 records · Latest accepted 2025/07/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502590 | Generic | 2025/07/18 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Dobutamine Hydrochloride Injection 5 records · Latest accepted 2024/12/09
Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402091 | Supplement | 2024/12/09 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHB2250455 | Supplement | 2022/07/25 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHB2250134 | Supplement | 2022/02/21 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHB2250133 | Supplement | 2022/02/21 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHB2101703 | Supplement | 2021/08/20 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
注射用硼[10B]法仑 · No verified English name 1 records · Latest accepted 2024/11/21
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2401266 | New drug | 2024/11/21 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
复方聚乙二醇(3350)电解质散 · No verified English name 2 records · Latest accepted 2024/10/15
Generic · 2
Gadobutrol Injection 6 records · Latest accepted 2024/09/30
Generic · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403317 | Generic | 2024/09/30 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2403316 | Generic | 2024/09/30 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2403315 | Generic | 2024/09/30 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2403314 | Generic | 2024/09/30 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2201216 | Generic | 2022/08/04 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2201215 | Generic | 2022/08/04 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
泊沙康唑注射液 · No verified English name 2 records · Latest accepted 2024/08/13
Supplement · 1Generic · 1
Naloxone Hydrochloride Injection 2 records · Latest accepted 2024/07/09
Generic · 2
Lacosamide Injection 3 records · Latest accepted 2024/06/12
Generic · 3
Dopamine Hydrochloride Injection 1 records · Latest accepted 2024/05/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401431 | Generic | 2024/05/12 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
注射用PLAT001 · No verified English name 1 records · Latest accepted 2024/05/11
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2400457 | New drug | 2024/05/11 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Calcium Folinate Injection 3 records · Latest accepted 2024/01/20
Generic · 3
Carfilzomib For Injection 1 records · Latest accepted 2024/01/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400131 | Generic | 2024/01/10 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Methocarbamol Injection 1 records · Latest accepted 2024/01/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400129 | Generic | 2024/01/10 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Iopamidol Injection 11 records · Latest accepted 2023/10/19
Supplement · 9Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302326 | Supplement | 2023/10/19 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHB2302325 | Supplement | 2023/10/19 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHB2302324 | Supplement | 2023/10/19 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHB2302323 | Supplement | 2023/10/19 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHB2302322 | Supplement | 2023/10/19 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHB2302321 | Supplement | 2023/10/19 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHB2302320 | Supplement | 2023/10/19 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHB2302319 | Supplement | 2023/10/19 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHB2302318 | Supplement | 2023/10/19 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2101594 | Generic | 2021/08/17 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2101593 | Generic | 2021/08/17 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Pentoxifylline Injection 1 records · Latest accepted 2023/09/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302430 | Generic | 2023/09/09 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Gadoteridol Injection 4 records · Latest accepted 2023/08/18
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302185 | Generic | 2023/08/18 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2302184 | Generic | 2023/08/18 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2302183 | Generic | 2023/08/18 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2302182 | Generic | 2023/08/18 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
硝普钠氯化钠注射液 · No verified English name 4 records · Latest accepted 2023/05/12
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301295 | Generic | 2023/05/12 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2301294 | Generic | 2023/05/12 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2301293 | Generic | 2023/05/12 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2301292 | Generic | 2023/05/12 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Voriconazole for Injection 2 records · Latest accepted 2023/04/21
Supplement · 1Generic · 1
Acyclovir Sodium Injection 1 records · Latest accepted 2023/02/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300547 | Generic | 2023/02/17 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Gadoteric Acid Meglumine Salt Injection 5 records · Latest accepted 2023/02/13
Generic · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300488 | Generic | 2023/02/13 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2300487 | Generic | 2023/02/13 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2300486 | Generic | 2023/02/13 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2300485 | Generic | 2023/02/13 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| CYHS2300484 | Generic | 2023/02/13 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Trimebutine Maleate Tablets 2 records · Latest accepted 2023/02/07
Supplement · 2
Diclofenac Sodium Enteric-Coated Sustained Release Capsules 1 records · Latest accepted 2023/01/06
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300042 | Supplement | 2023/01/06 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Nimodipine Injection 1 records · Latest accepted 2022/11/18
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250724 | Supplement | 2022/11/18 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Doxycycline Hyclate for Injection 2 records · Latest accepted 2022/09/29
Generic · 2
积雪苷片 · No verified English name 2 records · Latest accepted 2022/08/01
Supplement · 2
Tigecycline for Injection 1 records · Latest accepted 2022/07/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201112 | Generic | 2022/07/22 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
地氯雷他定分散片 · No verified English name 1 records · Latest accepted 2022/07/06
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201110 | Supplement | 2022/07/06 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Sodium Nitroprusside Injection 1 records · Latest accepted 2022/06/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201040 | Supplement | 2022/06/28 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Ganciclovir For Injection 2 records · Latest accepted 2022/05/12
Supplement · 2
Azithromycin for Suspension 3 records · Latest accepted 2022/04/11
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250211 | Supplement | 2022/04/11 | Hainan Poly Pharm. Co., Ltd.; Zhejiang Pu Li Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2250210 | Supplement | 2022/04/11 | Hainan Poly Pharm. Co., Ltd.; Zhejiang Pu Li Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2250209 | Supplement | 2022/04/11 | Hainan Poly Pharm. Co., Ltd.; Zhejiang Pu Li Pharma Co., Ltd. romanized | CDE ↗ |
Levetiracetam Concentrated Solution for Injection 2 records · Latest accepted 2021/12/08
Supplement · 2
Lincomycin Injection 2 records · Latest accepted 2021/09/07
Generic · 2
地氯雷他定干混悬剂 · No verified English name 2 records · Latest accepted 2021/08/03
Supplement · 2
Lansoprazole For Injection 1 records · Latest accepted 2021/07/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150724 | Supplement | 2021/07/09 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Daptomycin for Injection 2 records · Latest accepted 2021/06/10
Generic · 2
Esomeprazole Sodium for Injection 1 records · Latest accepted 2021/04/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101054 | Generic | 2021/04/14 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Changes in the last 90 days
0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
- No matching records were found in the currently loaded source data; coverage dates are listed below.
Under review
7 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Cyclophosphamide for Injection | CYHS2601918 | Generic | 2026/08/06 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| Cyclophosphamide for Injection | CYHS2601917 | Generic | 2026/08/06 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| Idarubicin Hydrochloride Injection | CYHS2503934 | Generic | 2025/11/12 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| Ioversol Injection | CYHS2503723 | Generic | 2025/10/17 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| Bivalirudin for Injection | CYHB2502026 | Supplement | 2025/10/15 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| Bumetanide Injection | CYHS2502591 | Generic | 2025/07/18 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| 维生素B6注射液 · No verified English name | CYHS2502590 | Generic | 2025/07/18 | Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
Catalogue holder records
67 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 复方聚乙二醇(3350)电解质散 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20265808 | 2026/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方聚乙二醇(3350)电解质散 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20265809 | 2026/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Naloxone Hydrochloride Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20263931 | 2026/04/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Naloxone Hydrochloride Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20263930 | 2026/04/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carfilzomib For Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20263523 | 2026/03/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadoteridol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20256161 | 2025/12/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadoteridol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20256159 | 2025/12/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadoteridol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20256158 | 2025/12/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadoteridol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20256160 | 2025/12/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lacosamide Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20255660 | 2025/09/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lacosamide Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20255661 | 2025/09/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iopamidol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20258123 | 2025/06/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iopamidol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20258122 | 2025/06/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iopamidol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20258111 | 2025/06/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iopamidol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20258109 | 2025/06/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iopamidol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20258110 | 2025/06/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iopamidol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20258112 | 2025/06/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iopamidol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20258108 | 2025/06/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Methocarbamol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字 H20254112 | 2025/05/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pentoxifylline Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20253867 | 2025/04/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 阿昔洛韦钠注射用浓溶液 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20253527 | 2025/03/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Phenylephrine Hydrochloride Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20253246 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Phenylephrine Hydrochloride Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20253247 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Doxycycline Hyclate for Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20249576 | 2024/12/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Doxycycline Hyclate for Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20249577 | 2024/12/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tigecycline for Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20244814 | 2024/09/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 泊沙康唑注射液 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20244110 | 2024/06/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadoteric Acid Meglumine Salt Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20244101 | 2024/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadoteric Acid Meglumine Salt Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20244098 | 2024/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadoteric Acid Meglumine Salt Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20244100 | 2024/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadoteric Acid Meglumine Salt Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20244097 | 2024/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadoteric Acid Meglumine Salt Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20244099 | 2024/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Trimebutine Maleate Tablets | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20000390 | 2024/05/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Trimebutine Maleate Tablets | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20040438 | 2024/05/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Vancomycin Hydrochloride for Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20243660 | 2024/05/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nimodipine Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20247004 | 2024/01/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Dobutamine Hydrochloride Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20237157 | 2023/11/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ganciclovir For Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20045933 | 2023/07/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Iopamidol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20233338 | 2023/03/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iopamidol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20233339 | 2023/03/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lincomycin Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20233308 | 2023/03/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lincomycin Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20233309 | 2023/03/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dobutamine Hydrochloride Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20237022 | 2023/03/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Dobutamine Hydrochloride Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20237021 | 2023/03/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Azithromycin for Suspension | Hainan Poly Pharm. Co., Ltd. | Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20237002 | 2023/01/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Azithromycin for Suspension | Hainan Poly Pharm. Co., Ltd. | Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20237007 | 2023/01/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Azithromycin for Suspension | Hainan Poly Pharm. Co., Ltd. | Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20057604 | 2023/01/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Daptomycin for Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20223945 | 2022/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Daptomycin for Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20223946 | 2022/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esomeprazole Sodium for Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20223705 | 2022/09/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 特利加压素注射液 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20223621 | 2022/08/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pantoprazole Sodium For Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20223636 | 2022/08/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lansoprazole For Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20203598 | 2022/06/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Voriconazole for Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20223340 | 2022/05/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Nitroprusside Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20223226 | 2022/04/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Eptifibatide Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20213587 | — | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metformin Hydrochloride Extended-release Tablets | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20040971 | 2021/05/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 地氯雷他定干混悬剂 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20041111 | 2021/03/08 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 地氯雷他定分散片 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20040972 | 2021/03/08 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 地氯雷他定干混悬剂 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20110018 | 2021/03/08 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ganciclovir For Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20183121 | 2020/12/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Bivalirudin for Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20203510 | 2020/09/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levetiracetam Concentrated Solution for Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20203415 | 2020/08/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadobutrol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20266015 | 2026/09/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadobutrol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20266013 | 2026/09/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadobutrol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20266016 | 2026/09/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadobutrol Injection | Hainan Poly Pharm. Co., Ltd. | Hainan Poly Pharm. Co., Ltd. | 国药准字H20266014 | 2026/09/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
20 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 布美他尼 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20240001076 | A | 2026/04/01 | CDE ↗ |
| 盐酸胺碘酮 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20210001090 | A | 2026/06/02 | CDE ↗ |
| 格隆溴铵 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20210000292 | A | 2025/10/30 | CDE ↗ |
| 阿昔洛韦钠 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20200001283 | A | 2025/03/14 | CDE ↗ |
| 艾司奥美拉唑钠 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20200001147 | A | 2024/01/17 | CDE ↗ |
| 地氯雷他定 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20190009677 | A | — | CDE ↗ |
| 更昔洛韦 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20190008046 | A | 2025/03/20 | CDE ↗ |
| 尼麦角林 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20190004851 | A | 2025/06/06 | CDE ↗ |
| 氢氧化镁 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20190004850 | A | 2025/06/11 | CDE ↗ |
| 马来酸曲美布汀 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20190004849 | A | 2024/11/02 | CDE ↗ |
| L-半胱氨酸 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20190004848 | A | 2025/06/28 | CDE ↗ |
| 盐酸多巴酚丁胺 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20190004626 | A | 2025/07/09 | CDE ↗ |
| 卡托普利 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20190002555 | A | 2024/07/16 | CDE ↗ |
| 富马酸酮替芬 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20190002543 | A | 2024/07/16 | CDE ↗ |
| 萘普生 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20190002532 | A | 2025/02/27 | CDE ↗ |
| 硝普钠 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20190000020 | A | 2024/03/14 | CDE ↗ |
| 地氯雷他定 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20180000812 | A | 2025/10/14 | CDE ↗ |
| 奥昔布宁 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20170001619 | I | — | CDE ↗ |
| 盐酸美金刚 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20170001437 | A | 2022/10/19 | CDE ↗ |
| 更昔洛韦钠 · No verified English name | Hainan Poly Pharm. Co., Ltd. | Y20170000518 | A | 2025/08/28 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
12 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Metformin Hydrochloride Extended-release Tablets | CYHB2501776 | Supplement | 2025/09/05 | Shanxi Hua Xia Tai Kang Pharmaceuticals Group Co., Ltd. romanized; Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| Sodium Nitroprusside Injection | CYHS2501479 | Generic | 2025/04/18 | Guangzhou Ze Sheng Pharma Technology Co., Ltd. romanized; Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| Dobutamine Hydrochloride Injection | CYHS2400707 | Generic | 2024/02/28 | Hainan Jian Tai Bio Technology Co., Ltd. romanized; Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| Esomeprazole Sodium for Injection | CYHB2302685 | Supplement | 2023/12/08 | SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED; Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| 盐酸纳洛酮 · No verified English name | JTH2300233 | Not stated by source | 2023/10/08 | Sun Pharmaceutical Industries Ltd; Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| 己酮可可碱 · No verified English name | JTH2200195 | Not stated by source | 2022/09/21 | Sun Pharmaceutical Industries Ltd.; Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| 伏立康唑 · No verified English name | JTH2200146 | Not stated by source | 2022/08/01 | Medichem S.A.; Midas Phanna GmbH; Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| 苯磺顺阿曲库铵 · No verified English name | JTH2100719 | Not stated by source | 2021/12/14 | Wavelength Enterprise LTD; Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| 伏立康唑 · No verified English name | JTH2100628 | Not stated by source | 2021/08/20 | Medichem S.A.; Midas Pharma GmbH; Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| 环磷酰胺 · No verified English name | JTH2100567 | Not stated by source | 2021/07/02 | MSN LABORATORIES PRIVATE LIMITED,Unit-II; Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| 盐酸多西环素 · No verified English name | JTH2100540 | Not stated by source | 2021/06/01 | Hovione PharmaScience Limited; Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
| 环磷酰胺 · No verified English name | JTH2100539 | Not stated by source | 2021/06/01 | MSN LABORATORIES PRIVATE LIMITED,Unit-II; Hainan Poly Pharm. Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.